aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate
Benzinga Newsdesk 2 weeks ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from
aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from the same period last year.
